CAMP4 Therapeutics (CAMP) News Today $4.51 +0.11 (+2.50%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$4.51 +0.00 (+0.11%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CAMP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period CAMP4 Therapeutics (NASDAQ:CAMP) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?1 hour ago | americanbankingnews.comCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)May 21 at 4:05 PM | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Celcuity (CELC), CAMP4 Therapeutics Corporation (CAMP) and Aquestive Therapeutics (AQST)May 16, 2026 | theglobeandmail.comCAMP4 Highlights Preclinical Progress of SYNGAP1 TherapyMay 14, 2026 | tipranks.comCAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related DisorderMay 14, 2026 | globenewswire.comCAMP4 Therapeutics (NASDAQ:CAMP) Stock Price Passes Above 200-Day Moving Average - Should You Sell?May 12, 2026 | americanbankingnews.comCAMP4 Reports First Quarter 2026 Financial Results and Corporate HighlightsMay 7, 2026 | globenewswire.comCAMP4 Therapeutics Corporation (NASDAQ:CAMP) Receives Average Rating of "Moderate Buy" from BrokeragesMay 3, 2026 | marketbeat.comShort Interest in CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Expands By 13.1%May 1, 2026 | marketbeat.comCAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene UpregulationApril 28, 2026 | globenewswire.comCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 17, 2026 | globenewswire.comRodman & Renshaw initiates coverage of Camp4 Therapeutics (CAMP) with buy recommendationApril 15, 2026 | msn.comCAMP4 Appoints Michael MacLean to its Board of DirectorsMarch 24, 2026 | finance.yahoo.comCAMP4 Therapeutics Adds Veteran CFO MacLean to BoardMarch 24, 2026 | tipranks.comCAMP4 Appoints Michael MacLean to its Board of DirectorsMarch 24, 2026 | globenewswire.comLeerink Partners Keeps Their Buy Rating on CAMP4 Therapeutics Corporation (CAMP)March 24, 2026 | theglobeandmail.comCAMP4 Therapeutics Corporation (CAMP) Receives a Buy from Piper SandlerMarch 24, 2026 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cooper Co (COO) and CAMP4 Therapeutics Corporation (CAMP)March 9, 2026 | theglobeandmail.com5CAMP : Camp4 Therapeutics Earnings Review: Q4 SummaryMarch 7, 2026 | benzinga.comCAMP4 to Participate in Upcoming Investor ConferencesMarch 6, 2026 | globenewswire.comCAMP4 Therapeutics: CAMP4 Reports Full Year 2025 Financial Results and Corporate HighlightsMarch 6, 2026 | finanznachrichten.deCAMP4 Highlights 2025 Results and SYNGAP1 Program ProgressMarch 5, 2026 | tipranks.comCAMP4 Reports Full Year 2025 Financial Results and Corporate HighlightsMarch 5, 2026 | globenewswire.comCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 20, 2026 | globenewswire.comCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)January 16, 2026 | globenewswire.comCamp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14, 2026 | seekingalpha.comCAMP4 Therapeutics updates corporate investor presentation materialsJanuary 9, 2026 | tipranks.comCAMP4 to Present at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2026 | globenewswire.comGetty Images, Torm, and more stocks see action from activist investorsJanuary 2, 2026 | msn.comCAMP4 Therapeutics Restructures Leases and Expands FacilitiesDecember 23, 2025 | tipranks.comCanadian GoldCamps Announces Management/Board Changes, Private Placement and Letter of Intent to Acquire Two Québec Gold ProjectsDecember 19, 2025 | globenewswire.comCamp4 Therapeutics stock falls after pricing $30 million share offeringDecember 19, 2025 | za.investing.comCamp4 Therapeutics shares slide after $30 million equity offering pricedDecember 19, 2025 | msn.comGSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: AnalystDecember 19, 2025 | benzinga.comCAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy RatingDecember 19, 2025 | tipranks.comCAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common StockDecember 18, 2025 | globenewswire.comCAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic DiscoveriesDecember 18, 2025 | globenewswire.comCAMP4 Therapeutics Grants Stock Options to New Employees as Part of Inducement PackageDecember 12, 2025 | quiverquant.comQCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 12, 2025 | globenewswire.comPositive week for Camp4 Therapeutics Corporation (NASDAQ:CAMP) institutional investors who lost 46% over the past yearDecember 10, 2025 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Rocket Pharmaceuticals (RCKT) and CAMP4 Therapeutics Corporation (CAMP)November 20, 2025 | theglobeandmail.comCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)November 14, 2025 | globenewswire.comStrategic Focus and Financial Strength Drive Buy Rating for CAMP4 TherapeuticsNovember 7, 2025 | tipranks.comCAMP4 Reports Third Quarter 2025 Financial Results and Corporate HighlightsNovember 6, 2025 | globenewswire.com3 Healthcare Companies Insiders Are BuyingOctober 14, 2025 | msn.com3 Healthcare Companies Insiders Are Buying October 14, 2025 | insidertrades.comCantor Fitzgerald Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight RecommendationOctober 3, 2025 | msn.comCamp4 Therapeutics initiated with an Overweight at Cantor FitzgeraldOctober 2, 2025 | msn.comCAMP4 Initiates GLP Toxicology Studies for CMP-SYNGAP-01October 1, 2025 | tipranks.comCAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 in SYNGAP1-Related DisordersOctober 1, 2025 | quiverquant.comQ Get CAMP4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CAMP Media Mentions By Week CAMP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CAMP News Sentiment▼0.000.44▲Average Medical News Sentiment CAMP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CAMP Articles This Week▼32▲CAMP Articles Average Week Get the Latest News and Ratings for CAMP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CAMP4 Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NTGR News Today RBBN News Today KVHI News Today AVNW News Today CMTL News Today AWRE News Today CSCO News Today QCOM News Today PANW News Today CIEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CAMP) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAMP4 Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CAMP4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
